Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.

@article{Robin2007AdherenceIG,
  title={Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.},
  author={Alan L. Robin and Gary D. Novack and David W Covert and Robert Crockett and Tania Sibila Marcic},
  journal={American journal of ophthalmology},
  year={2007},
  volume={144 4},
  pages={533-40}
}
PURPOSE To determine with electronic monitoring an objective measurement of adherence in two populations of subjects: those using once-daily prostaglandin analogs as sole ocular hypotensive therapy (one-drug group) and those requiring an adjunctive medicine to the prostaglandin analog (two-drug group). DESIGN Single-site, open-label, nonrandomized, parallel design of 60 days. METHODS Sixty-two consecutive adult subjects with a diagnosis of open-angle glaucoma (OAG) or ocular hypertension… CONTINUE READING